Correlation Between Enveric Biosciences and Inovio Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Enveric Biosciences and Inovio Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enveric Biosciences and Inovio Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enveric Biosciences and Inovio Pharmaceuticals, you can compare the effects of market volatilities on Enveric Biosciences and Inovio Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enveric Biosciences with a short position of Inovio Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enveric Biosciences and Inovio Pharmaceuticals.

Diversification Opportunities for Enveric Biosciences and Inovio Pharmaceuticals

0.76
  Correlation Coefficient

Poor diversification

The 3 months correlation between Enveric and Inovio is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Enveric Biosciences and Inovio Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inovio Pharmaceuticals and Enveric Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enveric Biosciences are associated (or correlated) with Inovio Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inovio Pharmaceuticals has no effect on the direction of Enveric Biosciences i.e., Enveric Biosciences and Inovio Pharmaceuticals go up and down completely randomly.

Pair Corralation between Enveric Biosciences and Inovio Pharmaceuticals

Given the investment horizon of 90 days Enveric Biosciences is expected to generate 1.72 times more return on investment than Inovio Pharmaceuticals. However, Enveric Biosciences is 1.72 times more volatile than Inovio Pharmaceuticals. It trades about -0.01 of its potential returns per unit of risk. Inovio Pharmaceuticals is currently generating about -0.04 per unit of risk. If you would invest  300.00  in Enveric Biosciences on August 26, 2024 and sell it today you would lose (266.00) from holding Enveric Biosciences or give up 88.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Enveric Biosciences  vs.  Inovio Pharmaceuticals

 Performance 
       Timeline  
Enveric Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Enveric Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Inovio Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Inovio Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Enveric Biosciences and Inovio Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Enveric Biosciences and Inovio Pharmaceuticals

The main advantage of trading using opposite Enveric Biosciences and Inovio Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enveric Biosciences position performs unexpectedly, Inovio Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inovio Pharmaceuticals will offset losses from the drop in Inovio Pharmaceuticals' long position.
The idea behind Enveric Biosciences and Inovio Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments